482 related articles for article (PubMed ID: 16081773)
1. Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells.
Pozzi LA; Maciaszek JW; Rock KL
J Immunol; 2005 Aug; 175(4):2071-81. PubMed ID: 16081773
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic cells are required to initiate a Chlamydia trachomatis-specific CD8+ T cell response.
Steele LN; Balsara ZR; Starnbach MN
J Immunol; 2004 Nov; 173(10):6327-37. PubMed ID: 15528372
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
[TBL] [Abstract][Full Text] [Related]
4. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
[TBL] [Abstract][Full Text] [Related]
5. Endogenous myelin basic protein is presented in the periphery by both dendritic cells and resting B cells with different functional consequences.
Seamons A; Perchellet A; Goverman J
J Immunol; 2006 Aug; 177(4):2097-106. PubMed ID: 16887968
[TBL] [Abstract][Full Text] [Related]
6. Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.
Hagymasi AT; Slaiby AM; Mihalyo MA; Qui HZ; Zammit DJ; Lefrancois L; Adler AJ
J Immunol; 2007 Aug; 179(3):1524-31. PubMed ID: 17641018
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
8. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
9. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
Lemos MP; Fan L; Lo D; Laufer TM
J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
[TBL] [Abstract][Full Text] [Related]
10. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells.
Zarling AL; Johnson JG; Hoffman RW; Lee DR
J Immunol; 1999 May; 162(9):5197-204. PubMed ID: 10227993
[TBL] [Abstract][Full Text] [Related]
11. Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells.
Perone MJ; Larregina AT; Shufesky WJ; Papworth GD; Sullivan ML; Zahorchak AF; Stolz DB; Baum LG; Watkins SC; Thomson AW; Morelli AE
J Immunol; 2006 Jun; 176(12):7207-20. PubMed ID: 16751364
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of CD8+ T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells.
Hamilton SE; Harty JT
J Immunol; 2002 Nov; 169(9):4936-44. PubMed ID: 12391206
[TBL] [Abstract][Full Text] [Related]
13. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection.
Wakim LM; Bevan MJ
Nature; 2011 Mar; 471(7340):629-32. PubMed ID: 21455179
[TBL] [Abstract][Full Text] [Related]
14. Manipulating the rate of memory CD8+ T cell generation after acute infection.
Badovinac VP; Harty JT
J Immunol; 2007 Jul; 179(1):53-63. PubMed ID: 17579021
[TBL] [Abstract][Full Text] [Related]
15. Induction of tolerance in CD8+ T cells to a transgenic autoantigen expressed in the liver does not require cross-presentation.
Morimoto J; Tan X; Teague RM; Ohlén C; Greenberg PD
J Immunol; 2007 Jun; 178(11):6849-60. PubMed ID: 17513733
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
[TBL] [Abstract][Full Text] [Related]
17. Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC.
Redmond WL; Hernandez J; Sherman LA
J Immunol; 2003 Dec; 171(12):6349-54. PubMed ID: 14662832
[TBL] [Abstract][Full Text] [Related]
18. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin.
Masopust D; Vezys V; Usherwood EJ; Cauley LS; Olson S; Marzo AL; Ward RL; Woodland DL; Lefrançois L
J Immunol; 2004 Apr; 172(8):4875-82. PubMed ID: 15067066
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis.
Mehal WZ; Azzaroli F; Crispe IN
J Immunol; 2001 Jul; 167(2):667-73. PubMed ID: 11441069
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo.
Wang JC; Livingstone AM
J Immunol; 2003 Dec; 171(12):6339-43. PubMed ID: 14662830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]